Etoricoxib Coated Tablets: Bioequivalence Assessment between Two Formulations Administered under Fasting Conditions

Etoricoxib is a non-steroidal anti-inflammatory drug with high selectivity for cyclooxygenase 2 (COX-2), exerting a pronounced anti-inflammatory effect with fewer adverse events when compared to COX-1 inhibitors. The present study aimed to evaluate the bioequivalence between two etoricoxib-coated ta...

Descripción completa

Detalles Bibliográficos
Autores principales: Meulman, Jessica, Davanço, Marcelo Gomes, Vianna, Débora Renz Barreto, da Silva, Thalita Martins, Costa, Fernando, Pacheco, Fernando Bastos Canton, de Oliveira, Milla Emke, Vespasiano, Celso Francisco Pimentel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675291/
https://www.ncbi.nlm.nih.gov/pubmed/38004548
http://dx.doi.org/10.3390/pharmaceutics15112569

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675291/
https://www.ncbi.nlm.nih.gov/pubmed/38004548
http://dx.doi.org/10.3390/pharmaceutics15112569

Ejemplares similares